Showing results (351-360 of 384) with videos related to
Sort By:
Pageof 39
BMJ Open|February 4, 2026
Hydrocortisone replacement therapy in patients with glucocorticoid withdrawal syndrome after cessation of glucocorticoid treatment: REPLACE, a multicentre, randomised, double-blinded, placebo-controlled, 16-week study protocolAnja Fenger Dreyer, Simon Bøggild Hansen, Stina Willemoes Borresen, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 11, 2019
Thyroid Related Quality of Life in Elderly with Subclinical Hypothyroidism and Improvement on Levothyroxine is Distinct from that in Young Patients (TSAGE)Stefanie Recker, Richard Voigtländer, Anja Viehmann, et al.Hormone Research in Paediatrics|December 1, 2025
EndoCompass Project: Research Roadmap for Thyroid EndocrinologyAgnieszka Piekielko-Witkowska, Rossella Elisei, Juliane Léger, et al.European Journal of Endocrinology|October 17, 2025
EndoCompass project: research roadmap for thyroid endocrinologyAgnieszka Piekiełko-Witkowska, Rossella Elisei, Juliane Leger, et al.BMJ Open|June 11, 2026
Effect of supplemental hydrocortisone during stress in prednisolone-induced adrenal insufficiency: a study protocol for a multicentre, randomised, double-blinded, placebo-controlled clinical trial on health-related quality of life in patients with polymyalgia rheumatica/giant cell arteritis on low-dose prednisolone treatment (the RESCUE study)Stina Willemoes Borresen, Simon Bøggild Hansen, Hajir Al-Jorani, et al.Molecular Genetics and Metabolism|July 19, 2018
European expert consensus statement on therapeutic goals in Fabry diseaseChristoph Wanner, Michael Arad, Ralf Baron, et al.European Thyroid Journal|January 12, 2024
Selenium supplementation and placebo are equally effective in improving quality of life in patients with hypothyroidismCamilla Larsen, Kristian Hillert Winther, Per Karkov Cramon, et al.Annals of Internal Medicine|May 5, 2020
L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized TrialMaria de Montmollin, Martin Feller, Shanthi Beglinger, et al.JIMD Reports|February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortageGabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.JAMA Network Open|March 18, 2025
Changes in Adrenal Function and Insufficiency Symptoms After Cessation of PrednisoloneSimon Bøggild Hansen, Anja Fenger Dreyer, Nanna Thurmann Jørgensen, et al.Pageof 39